Overview
Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions
Status:
Completed
Completed
Trial end date:
2013-03-01
2013-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The objective of the current study is to investigate the relative bioavailability of two different doses of BI 201335, administered as soft gelatine capsule in comparison to the equivalent doses of three different oral solution per dose of BI 201335.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Boehringer IngelheimTreatments:
Pharmaceutical Solutions
Criteria
Inclusion criteria:1. Healthy male and female subjects
Exclusion criteria:
Any relevant deviation from healthy conditions